Trimeris Reformulates Strategy
Price: 200
Add to Cart
Details
Case Code:
CLBS093
Case Length:
2
Period:
Pub Date:
2009
Teaching Note:
NO
Price (Rs):
200
Organization:
Trimeris Inc.
Industry:
Pharmaceuticals & Biotech
Country:
US
Themes:
Market Analysis,New Product Development, Product Management
Abstract
With sales of its only commercially available product failing to pick up significantly and the company being encircled by a number of problems, Trimeris announced its plans to downsize the company by scaling back its investments in research and development (R&D) and laying off workers.
Learning Objectives
The case is structured to achieve the following Learning Objectives:
- 0
Keywords
Strategy, Trimeris, downsizing, research and development, fusion inhibitor technology, Fuzeon, TRI-1144, HealthCor, patent infringement, Novartis, drug delivery system, Pfizer, Merck, Roche
Related Case Studies
| Case Title | Details | Price | Add to Cart |
|---|---|---|---|
|
Case Title Burger King’s Satisfries: The Failed French FryCase Code: CLCB067 |
Details | 200 | Add to Cart |
|
Case Title Debacle of Google GlassCase Code: CLCB066 |
Details | 200 | Add to Cart |
|
Case Title Rolls-Royce: The Turnaround ChallengeCase Code: CLBS154 |
Details | 200 | Add to Cart |
|
Case Title Innovation at Tesla MotorsCase Code: CLBS150 |
Details | 200 | Add to Cart |
|
Case Title JBS S.A.: A Latin American Success StoryCase Code: BSTR497 |
Details | 700 | Add to Cart |